The N-methyl-D-aspartic acid receptor antagonist memantine ameliorates and delays the development of arthritis by enhancing regulatory T cells

NeuroSignals

Volumn 20, Issue 2, 2012, Pages 61-71

  Lindblad, Sofia S ^a,b   Mydel, Piotr ^a   Hellvard, Annelie ^a   Jonsson, Ing Marie ^a   Bokarewa, Maria I ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Collagen induced arthritis; N Methyl D aspartic acid receptor; Regulatory T cells

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; COLLAGEN TYPE 2; GLUTAMATE RECEPTOR; KYNURENIC ACID; MEMANTINE; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; EROSION; IMMUNIZATION; MALE; MOUSE; NONHUMAN; OSTEOLYSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN; SYNOVITIS; T LYMPHOCYTE SUBPOPULATION; UPREGULATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CD4-POSITIVE T-LYMPHOCYTES; COLLAGEN TYPE II; MALE; MEMANTINE; MICE; MICE, INBRED DBA; RECEPTORS, N-METHYL-D-ASPARTATE; T-LYMPHOCYTES, REGULATORY;

EID: 84859006923     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000329551     Document Type: Article

References (54)

1. Andersson AK, Li C, Brennan FM: Recent developments in the immunobiology of rheumatoid arthritis. Arthritis Res Ther 2008; 10: 204.
2. Beech JT, Andreakos E, Ciesielski CJ, Green P, Foxwell BM, Brennan FM: T-cell contactdependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NF-B: implications for rheumatoid arthritis. Arthritis Res Ther 2006; 8:R168.
3. Tran CN, Lundy SK, White PT, Endres JL, Motyl CD, Gupta R, et al: Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-on cytokine-activated T cells. Am J Pathol 2007; 171: 1588-1598. (Pubitemid 350158319)
4. Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, et al: Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 2001; 44: 1003-1012. (Pubitemid 32433604)
5. Fournier C: Where do T cells stand in rheumatoid arthritis? Joint Bone Spine 2005; 72: 527-532. (Pubitemid 41821411)
6. Meldrum BS: Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 2000; 130(suppl 4):1007S- 1015S. (Pubitemid 30173635)
7. McNearney T, Baethge BA, Cao S, Alam R, Lisse JR, Westlund KN: Excitatory amino acids, TNF-, and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol 2004; 137: 621-627. (Pubitemid 39128094)
8. McNearney T, Speegle D, Lawand N, Lisse J, Westlund KN: Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheumatol 2000; 27: 739-745. (Pubitemid 30151357)
9. Lawand NB, McNearney T, Westlund KN: Amino acid release into the knee joint: key role in nociception and inflammation. Pain 2000; 86: 69-74. (Pubitemid 30211704)
10. Hinoi E, Ohashi R, Miyata S, Kato Y, Iemata M, Hojo H, et al: Excitatory amino acid transporters expressed by synovial fibroblasts in rats with collagen-induced arthritis. Biochem Pharmacol 2005; 70: 1744-1755. (Pubitemid 41612005)
11. Piepoli T, Mennuni L, Zerbi S, Lanza M, Rovati LC, Caselli G: Glutamate signaling in chondrocytes and the potential involvement of NMDA receptors in cell proliferation and inflammatory gene expression. Osteoarthritis Cartilage 2009; 17: 1076-1083.
12. Flood S, Parri R, Williams A, Duance V, Mason D: Modulation of interleukin-6 and matrix metalloproteinase 2 expression in human fibroblast-like synoviocytes by functional ionotropic glutamate receptors. Arthritis Rheum 2007; 56: 2523-2534. (Pubitemid 47237271)
13. Boldyrev AA, Carpenter DO, Johnson P: Emerging evidence for a similar role of glutamate receptors in the nervous and immune systems. J Neurochem 2005; 95: 913-918. (Pubitemid 41713477)
14. Yanamala N, Tirupula KC, Klein-Seetharaman J: Preferential binding of allosteric modulators to active and inactive conformational states of metabotropic glutamate receptors. BMC Bioinformatics 2008; 9(suppl 1):S16.
15. Chen PE, Geballe MT, Stansfeld PJ, Johnston AR, Yuan H, Jacob AL, et al: Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl- D -aspartate receptors determined by site-directed mutagenesis and molecular modeling. Mol Pharmacol 2005; 67: 1470-1484. (Pubitemid 40594146)
16. Cull-Candy SG, Leszkiewicz DN: Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004; 2004:re16.
17. Huggins DJ, Grant GH: The function of the amino terminal domain in NMDA receptor modulation. J Mol Graph Model 2005; 23: 381-388. (Pubitemid 40164751)
18. Berti M, Baciarello M, Troglio R, Fanelli G: Clinical uses of low-dose ketamine in patients undergoing surgery. Curr Drug Targets 2009; 10: 707-715.
19. Leander JD, Lawson RR, Ornstein PL, Zimmerman DM: N-methyl- D -aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs. Brain Res 1988; 448: 115-120.
20. Kumari M, Ticku MK: Regulation of NMDA receptors by ethanol. Prog Drug Res 2000; 54: 152-189.
21. Pin JP, Duvoisin R: The metabotropic glutamate receptors: structure and functions. Neuropharmacology 1995; 34: 1-26.
22. Swanson CJ, Bures M, Johnson MP, Linden AM, Monn JA, Schoepp DD: Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov 2005; 4: 131-144. (Pubitemid 40277494)
23. Skeberdis VA, Lan J, Opitz T, Zheng X, Bennett MV, Zukin RS: mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C. Neuropharmacology 2001; 40: 856-865. (Pubitemid 32510799)
24. Levite M: Nervous immunity: neurotransmitters, extracellular K + and T-cell function. Trends Immunol 2001; 22: 2-5. (Pubitemid 32675266)
25. Gonoi T, Mizuno N, Inagaki N, Kuromi H, Seino Y, Miyazaki J, Seino S: Functional neuronal ionotropic glutamate receptors are expressed in the non-neuronal cell line MIN6. J Biol Chem 1994; 269: 16989-16992. (Pubitemid 24204010)
26. Kvaratskhelia E, Maisuradze E, Dabrundashvili NG, Natsvlishvili N, Zhuravliova E, Mikeladze DG: N-methyl- D -aspartate and sigma-ligands change the production of interleukins and 10 in lymphocytes through modulation of the NMDA glutamate receptor. Neuroimmunomodulation 2009; 16: 201-207.
27. Pacheco R, Ciruela F, Casado V, Mallol J, Gallart T, Lluis C, et al: Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation. J Biol Chem 2004; 279: 33352-33358. (Pubitemid 39062983)
28. Johnson JW, Kotermanski SE: Mechanism of action of memantine. Curr Opin Pharmacol 2006; 6: 61-67. (Pubitemid 43103820)
29. Toggas SM, Masliah E, Mucke L: Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res 1996; 706: 303-307. (Pubitemid 26046728)
30. Verdrengh M, Jonsson IM, Holmdahl R, Tarkowski A: Genistein as an anti-inflammatory agent. Inflamm Res 2003; 52: 341-346. (Pubitemid 36995159)
31. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al: Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-1886. (Pubitemid 38032120)
32. Amu S, Gjertsson I, Tarkowski A, Brisslert M: B-cell CD25 expression in murine primary and secondary lymphoid tissue. Scand J Immunol 2006; 64: 482-492. (Pubitemid 44536333)
33. Lindblad SS, Mydel P, Jonsson IM, Senior RM, Tarkowski A, Bokarewa M: Smoking and nicotine exposure delay development of collagen-induced arthritis in mice. Arthritis Res Ther 2009; 11:R88.
34. Holmdahl R, Jansson L, Larsson A, Jonsson R: Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies. Scand J Immunol 1990; 31: 147-157. (Pubitemid 20049601)
35. Boettger MK, Weber K, Gajda M, Bruer R, Schaible HG: Spinally applied ketamine or morphine attenuate peripheral inflammation and hyperalgesia in acute and chronic phases of experimental arthritis. Brain Behav Immun 2010; 24: 474-485.
36. da Cunha AA, Pauli V, Saciura VC, Pires MG, Constantino LC, de Souza B, Petronilho F, Rodrigues de Oliveira J, Ritter C, Romo PR, Boeck CR, Roesler R, Quevedo J, Dal- Pizzol F: N-methyl- D -aspartate glutamate receptor blockade attenuates lung injury associated with experimental sepsis. Chest 2010; 137: 297-302.
37. Varga G, Erces D, Fazekas B, Fülöp M, Kovács T, Kaszaki J, Fülöp F, Vcsei L, Boros M: N-Methyl- D -aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat. Neurogastroenterol Motil 2010; 22: 217-225.
38. Lam FF, Ng ES: Substance P and glutamate receptor antagonists improve the anti-arthritic actions of dexamethasone in rats. Br J Pharmacol 2010; 159: 958-969.
39. Sluka KA, Jordan HH, Westlund KN: Reduction in joint swelling and hyperalgesia following post-treatment with a non-NMDA glutamate receptor antagonist. Pain 1994; 59: 95-100. (Pubitemid 24311174)
40. Ivanusic JJ, Beaini D, Hatch RJ, Staikopou - los V, Sessle BJ, Jennings EA: Peripheral Nmethyl- D -aspartate receptors contribute to mechanical hypersensitivity in a rat model of inflammatory temporomandibular joint pain. Eur J Pain 2011; 15: 179-185.
41. Sluka KA, Westlund KN: Centrally administered non-NMDA but not NMDA receptor antagonists block peripheral knee joint inflammation. Pain 1993; 55: 217-225. (Pubitemid 23323169)
42. Mason DJ, Suva LJ, Genever PG, Patton AJ, Steuckle S, Hillam RA, et al: Mechanically regulated expression of a neural glutamate transporter in bone: a role for excitatory amino acids as osteotropic agents? Bone 1997; 20: 199-205. (Pubitemid 27141830)
43. Lin TH, Yang RS, Tang CH, Wu MY, Fu WM: Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate. Eur J Pharmacol 2008; 589: 37-44.
44. Chenu C, Serre CM, Raynal C, Burt-Pichat B, Delmas PD: Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone 1998; 22: 295-299. (Pubitemid 28177180)
45. Patton AJ, Genever PG, Birch MA, Suva LJ, Skerry TM: Expression of an N-methyl-Daspartate- type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone. Bone 1998; 22: 645-649. (Pubitemid 28284613)
46. Laketic-Ljubojevic I, Suva LJ, Maathuis FJ, Sanders D, Skerry TM: Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. Bone 1999; 25: 631-637. (Pubitemid 29525428)
47. Miglio G, Dianzani C, Fallarini S, Fantozzi R, Lombardi G: Stimulation of N-methyl-Daspartate receptors modulates Jurkat T cell growth and adhesion to fibronectin. Biochem Biophys Res Commun 2007; 361: 404-409. (Pubitemid 47193116)
48. Mashkina AP, Tyulina OV, Solovyova TI, Kovalenko EI, Kanevski LM, Johnson P, et al: The excitotoxic effect of NMDA on human lymphocyte immune function. Neurochem Int 2007; 51: 356-360. (Pubitemid 47503464)
49. Fontenot JD, Rudensky AY: A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005; 6: 331-337. (Pubitemid 41716769)
50. Feuerer M, Hill JA, Mathis D, Benoist C: Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 2009; 10: 689-695.
51. Wing K, Sakaguchi S: Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010; 11: 7-13.
52. Luross JA, Williams NA: The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology 2001; 103: 407-416. (Pubitemid 32744386)
53. Watson WC, Brown PS, Pitcock JA, Townes AS: Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57Bl/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis. Arthritis Rheum 1987; 30: 460-465. (Pubitemid 17080787)
54. Morgan ME, Flierman R, van Duivenvoorde LM, Witteveen HJ, van Ewijk W, van Laar JM, et al: Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 2005; 52: 2212-2221. (Pubitemid 40994344)